Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of xanthine oxidase inhibition with allopurinol on cardiac energetics in chronic heart failure
2009-015958-38Phase 4Terminated
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of allopurinol in chronic heart failure (CHF), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Change in myocardial PCr/ATP ratio. Started Sep 2009; status: terminated.
02
Drugs
allopurinol
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2009-015958-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015958-38.